FibroGen Inc.

NASDAQ: FGEN · Real-Time Price · USD
9.49
0.01 (0.11%)
At close: Aug 15, 2025, 3:59 PM
9.44
-0.58%
After-hours: Aug 15, 2025, 07:24 PM EDT

FibroGen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
-72.84M -23.54M -918K 149.48M 143.28M 136.96M 147.75M 154.98M 130.58M 116.07M 140.74M 122.91M 263.15M 257.71M 235.31M 283.76M 171.82M 190.35M
Cost of Revenue
-15.12M -9.94M 11.15M 37.22M 36.17M 36.7M 18.85M 18.37M 18.43M 19.53M 20.28M 18.48M 17.44M 13.71M 12.87M 12.36M 11.3M 11.3M
Gross Profit
-59.06M -13.6M -12.07M 112.25M 107.11M 100.25M 128.9M 136.61M 112.15M 96.54M 120.45M 104.43M 245.71M 244M 222.44M 271.4M 160.52M 179.05M
Operating Income
-117.29M -116.15M -150.42M -171.98M -218.68M -295.81M -322.72M -293.77M -323.95M -314.12M -301.03M -370.12M -225.48M -281.1M -288.53M -211.29M -229.93M -181.23M
Interest Income
4.21M 3.27M 5.09M 7.59M 8.08M 11.68M 10.48M 8.91M 6.41M 8.96M 8.24M 8.36M 6.9M 2.27M 1.95M 1.18M 2.32M 2.4M
Pretax Income
-117.88M -119.92M -152.19M -175.94M -221.5M -294.16M -322.55M -295.77M -324.18M -308.88M -294.87M -362.83M -221.32M -282.71M -290.68M -214.84M -231.18M -181.77M
Net Income
-2.07M -10.01M -47.58M -121.79M -168.32M -240.46M -284.23M -294.45M -322.49M -308M -294.82M -362.44M -221M -281.79M -290.02M -214.58M -231.37M -182.7M
Selling & General & Admin
19.4M 34.62M 43.22M 80.77M 88.79M 97.69M 115.25M 125M 129.32M 128.4M 124.69M 125.46M 121.41M 123.71M 123.92M 131.44M 56.6M 87.58M
Research & Development
38.23M 66.47M 93.79M 144.01M 183.49M 244.86M 282.86M 292.79M 306.77M 282.26M 296.79M 349.08M 349.78M 401.38M 387.04M 351.26M 333.85M 272.7M
Other Expenses
19.58M 19.58M 19.45M 18.55M 12.61M 12.61M 12.61M 12.61M n/a n/a n/a n/a n/a n/a -453K -453K -453K -453K
Operating Expenses
77.21M 120.67M 156.47M 243.33M 284.88M 355.16M 410.72M 430.39M 436.1M 410.66M 421.48M 474.55M 471.19M 525.1M 510.97M 482.69M 390.45M 360.28M
Interest Expense
7.46M 15.53M 15.37M 18.22M 18.25M 15.25M 15.53M 11.58M 6.64M 3.72M 1.76M 754K 2.08M 2.66M 2.74M 3.17M 2.34M 2.27M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -64.16M -64.16M -64.16M
Cost & Expenses
62.57M 110.73M 167.62M 280.55M 321.06M 391.86M 429.57M 448.75M 454.53M 430.19M 441.76M 493.03M 488.63M 538.8M 523.84M 495.05M 401.75M 371.58M
Income Tax Expense
-76K -246K -241K -418K -346K -319K -252K 31K 61K 319K 358K 362K 354K 328K 349K 408K 517K 689K
Shares Outstanding (Basic)
4.04M 100.95M 100.83M 100.52M 99.83M 98.98M 98.5M 98.25M 97.73M 94.69M 94.03M 93.77M 93.47M 93.04M 92.69M 92.64M 92.28M 91.69M
Shares Outstanding (Diluted)
4.04M 100.95M 100.83M 100.52M 99.83M 98.98M 98.5M 98.25M 97.73M 94.69M 94.03M 93.77M 93.47M 93.04M 92.77M 92.81M 92.28M 91.69M
EPS (Basic)
-1.82 -0.1 -0.48 -1.23 -1.71 -2.45 -2.93 -3.07 -3.4 -3.28 -3.15 -3.89 -2.37 -3.04 -3.14 -2.33 -2.51 -2.01
EPS (Diluted)
-1.82 -0.1 -0.48 -1.23 -1.71 -2.45 -2.93 -3.07 -3.4 -3.28 -3.15 -3.89 -2.37 -3.04 -3.14 -2.33 -2.52 -2.02
EBITDA
-129.57M -127.66M -159.6M -118.33M -162.9M -235.44M -261.41M -274.12M -306.49M -294.18M -282.5M -352.62M -209.88M -269.04M -273.72M -193.5M -209.16M -158.59M
EBIT
-118.94M -129.85M -162.29M -122.54M -168.75M -243.23M -271.34M -284.87M -317.54M -305.17M -293.11M -363.12M -221.59M -282.4M -289.83M -212.52M -228.38M -179.03M
Depreciation & Amortization
1.42M 2.2M 2.69M 4.21M 5.85M 7.79M 9.93M 10.74M 11.05M 10.98M 10.6M 10.5M 10.41M 12.05M 14.81M 17.72M 20.7M 21.92M